//dianhuaminglu.com/en/junshi-biosciences-announces-updated-clinical-data-from-phase-i-study-of-anti-btla-antibody-tifcemalimab-in-treatment-of-relapsed-refractory-lymphomas-at-64th-ash-annual-meeting/ 创新疗法的发现、开发和商业化的生物制药公司�?/description> Thu, 04 May 2023 10:31:25 +0000 hourly 1 //wordpress.org/?v=6.6.2